X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 54 filers reported holding X4 PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $428,000 | +54.0% | 250,144 | 0.0% | 0.26% | +60.7% |
| Q2 2022 | $278,000 | -36.5% | 250,144 | 0.0% | 0.16% | -19.3% |
| Q1 2022 | $438,000 | -43.8% | 250,144 | -26.5% | 0.20% | -47.7% |
| Q4 2021 | $780,000 | -61.8% | 340,495 | -11.9% | 0.39% | -58.0% |
| Q3 2021 | $2,044,000 | -6.0% | 386,475 | +15.5% | 0.92% | +13.6% |
| Q2 2021 | $2,175,000 | – | 334,684 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 6,247,500 | $6,809,775 | 2.18% |
| Bain Capital Life Sciences Investors, LLC | 15,960,588 | $17,397,041 | 1.94% |
| Stonepine Capital Management, LLC | 5,273,685 | $5,748,317 | 1.91% |
| NEA Management Company, LLC | 14,986,793 | $16,335,604 | 1.26% |
| Sio Capital Management, LLC | 2,599,003 | $2,832,913 | 0.88% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $365,150 | 0.47% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,973,683 | $2,151,314 | 0.25% |
| Monashee Investment Management LLC | 427,265 | $465,719 | 0.20% |
| Orbimed Advisors | 7,133,515 | $7,775,531 | 0.16% |
| Parkman Healthcare Partners LLC | 800,000 | $872,000 | 0.16% |